Truveta Secures $320 Million in Series C Funding to Revolutionize Healthcare Data

We are thrilled to announce that Truveta, the pioneering collective of health systems dedicated to Saving Lives with Data, has successfully raised $320 million in a recent funding round. This significant investment is a testament to the trust and confidence our partners and investors place in our mission to transform healthcare through innovative data solutions. With our state-of-the-art platform delivering the most complete, clean, and timely regulatory-grade Electronic Health Record (EHR) data, we empower leading life science, government, health system, academic, and research organizations to conduct scientifically rigorous research. The funds raised will be strategically allocated towards the expansion of our capabilities to enhance data collection and analysis, enabling the acceleration of new therapies and improving the efficiency of clinical trials. Moreover, this investment will bolster our ongoing efforts to refine patient care initiatives, ensuring that healthcare providers can deliver tailored, evidence-based treatments to patients in a timely manner. As Truveta continues to grow, we remain committed to harnessing the power of data to make a meaningful impact on health outcomes across the nation, ultimately paving the way for a healthier future for all. We are grateful to our supporters who share our vision and mission, and we are excited about the opportunities this funding opens up to further innovate and elevate the standard of care through actionable insights.